We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Worldwide Healthcare Trust plc (WWH) ORD GBP0.025

Sell:329.00p Buy:329.50p 0 Change: 3.50p (1.07%)
FTSE 250:0.78%
Market closed Prices as at close on 28 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend today
Sell:329.00p
Buy:329.50p
Change: 3.50p (1.07%)
Market closed Prices as at close on 28 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend today
Sell:329.00p
Buy:329.50p
Change: 3.50p (1.07%)
Market closed Prices as at close on 28 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend today
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
325.00p
Trade high:
330.00p
Year high:
372.00p
Estimated NAV:
380.79
Previous close:
326.50p
Trade low:
325.00p
Year low:
294.00p
Premium/Discount:
-14.26%
Previous:
0.00p (0.00%)
Previous:
0.00p
Volume:
1,104,607
Dividend yield:
0.85%
Currency:
GBX
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
WORLDWIDE HC performance chart

Premium/Discount

WORLDWIDE HC performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 1.08% 1 year 1Y 10.12%
1 month 1M 5.09% 2 years 2Y 1.21%
3 months 3M 10.43% 3 years 3Y 8.29%
6 months 6M 6.04% 5 years 5Y 8.83%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: MSCI World Health Care GR
Annual management charge: n/a
Performance fee: Yes
Ongoing charge: 0.90%
Dividend yield: 0.85%
Dividend frequency: Semi-Annually
Total assets: £2,006m
Gross gearing: 2%
Market capitalisation:Market cap.: £1,672m
Shares in issue: 511.67 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB00BN455J50

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents



Objective

In order to achieve a high level of capital growth, the Company invests in the global healthcare sector and in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to mitigate risk and also to enhance returns.

NET ASSET VALUE (NAV)

Estimated NAV: 380.79p
Latest actual NAV: 387.80p
Latest actual NAV date: 26 November 2024
Premium/Discount: -14.26%
12m average Premium/Discount: -10.48%
NAV frequency: Daily
Security Weight
Eli Lilly and Co 8.94%
AstraZeneca plc Ordinary US$0.25 7.29%
Boston Scientific Corp 7.19%
Intuitive Surgical Inc 6.54%
Novo Nordisk DKK0.1 B 6.43%
Merck & Co Inc 4.81%
Daiichi Sankyo Co Ltd 4.80%
Tenet Healthcare Corp 4.65%
Biogen Inc 4.38%
UnitedHealth Group Inc 3.89%
Sector Weight
Healthcare 97.24%
Country Weight
United States 72.62%
United Kingdom 7.29%
Japan 7.11%
Denmark 6.43%
China 3.14%
Hong Kong 0.64%

Key Dates

Launch date: 28 April 1995
Financial year end: March
Next AGM: July 2025
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.